Harvard Heart Letter

Promising news about heart failure

Serelaxin, a new drug derived from hormones that cause muscle relaxation, appears to reduce the symptoms of heart failure, organ damage from poor blood flow, and heart failure deaths.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In